Search Results 531-540 of 21362 for anti-TNF drugs

  1. Artemether And Lumefantrine (Oral Route) Description and Brand Names - Mayo Clinic

    Artemether and lumefantrine combination belongs to a group of medicines known as antimalarials. It treats malaria, a red blood cell infection transmitted by ...

  2. Infectious diseases - Diagnosis & treatment - Mayo Clinic

    More-severe internal organ fungal infections, especially in people with weakened immune systems, may require intravenous antifungal medications. Anti-parasitics.

  3. Corticosteroid (Dental Route) Description and Brand Names - Mayo Clinic

    Descriptions. Dental corticosteroids are used to relieve the discomfort and redness of some mouth and gum problems. These medicines are like cortisone. They ...

  4. Some pain medicines may increase heart attack risk after surgery - Mayo Clinic News Network

    In a McGill University study published recently in the British Medical Journal, researchers found that post-surgery use of nonsteroidal anti-inflammatory drugs ...

  5. Milk thistle - Mayo Clinic

    Milk thistle may affect how your liver processes this osteoporosis medication, causing higher levels of the drug in your bloodstream. Talk to your doctor before ...

  6. TUESDAY Q & A: Work with your doctor to weigh pros, cons of treatment options for hyperthyroidism - Mayo Clinic News Network

    Each has risks and benefits. Anti-thyroid medications generally bring thyroid hormone levels down to normal and reduce hyperthyroidism symptoms. However, due to ...

  7. Zinc - Mayo Clinic

    People use oral zinc to help treat colds, but it can decrease the effectiveness of certain drugs and cause side effects. ... These blood pressure drugs increase ...

  8. SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry - Mayo Clinic

    Patient is currently receiving anti-TNF treatment for ≤12 months. Patient must receive anti-TNF treatment within 2 months following enrollment into the ...

  9. An Open-label Study Using ASP-1929 Photoimmunotherapy in Combination With Anti-PD1 Therapy in EGFR Expressing Advanced Solid Tumors - Mayo Clinic

    Open-label study using ASP-1929 photoimmunotherapy in combination with anti-PD1 therapy in patients with recurrent or metastatic head and neck and squamous cell ...

  10. Data From Worldwide Trial of Two HER2-Positive Breast Cancer Drugs Shows That Trastuzumab Should Remain as Standard of Care - Mayo Clinic News Network

    Dual blockade using two anti-HER2 drugs only increased toxicity, said Dr. Perez. This new analysis compared use of lapatinib or trastuzumab alone, as well ...